Incannex Healthcare Inc. IXHL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | -100.00% | -86.05% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -100.00% | -100.00% | -86.05% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -100.00% | -100.00% | -86.05% | -- |
| SG&A Expenses | 35.73% | 22.06% | -0.52% | -16.07% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.95% | 20.42% | 14.97% | -1.43% | -- |
| Operating Income | 16.63% | -21.00% | -15.49% | 1.11% | -- |
| Income Before Tax | 58.83% | -122.97% | -103.98% | -107.03% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 58.83% | -122.66% | -103.73% | -106.76% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.83% | -122.66% | -103.73% | -106.76% | -- |
| EBIT | 16.63% | -21.00% | -15.49% | 1.11% | -- |
| EBITDA | 16.53% | -21.63% | -15.77% | 1.81% | -- |
| EPS Basic | 95.38% | 64.83% | 55.62% | 32.87% | -- |
| Normalized Basic EPS | 95.16% | 63.75% | 59.59% | 36.83% | -- |
| EPS Diluted | 95.38% | 64.83% | 55.62% | 32.87% | -- |
| Normalized Diluted EPS | 95.16% | 63.75% | 59.59% | 36.83% | -- |
| Average Basic Shares Outstanding | 913.49% | 1,447.65% | 1,018.41% | 548.34% | -- |
| Average Diluted Shares Outstanding | 913.49% | 1,447.65% | 1,018.41% | 548.34% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |